The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
FS KKR Capital Corp.
FSK · the NYSE · USD · Market cap $3.4B
FS KKR Capital Corp.
FAIL · Does not pass the screenAt the last full screen
2026-09-04
Screened 2026-09-04 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
FS KKR Capital Corp. holds its Distribution at $12.44. The statistical read favours the sellers, held for 63 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 63 days |
| Price at the screen | $12.44 |
| Valuation | N/A trailing · 8.28 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.91 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: financial services | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-04 screen. The gold marker is the market price at the same screen. A 2.6% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Hold. The average target sits −4% from the screen price.
Reading the gap · Our model and the Street both land near today's price: fairly valued, with no strong edge either way.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsMiddle Market Lender Trips Our Ethical Line
Picture a pension fund manager hunting yield by funding loans to mid-sized US firms that banks have turned away. FS KKR Capital Corp sits in exactly that spot, packaging senior debt for those borrowers. Yet the position fails our ethical screen outright because the whole sector carries a prohibited keyword.
The numbers reinforce why we pass. Revenue is down 24 percent, the profit margin sits at minus 39 percent and return on equity is negative 9 percent. A forward multiple of 7.1 times looks cheap until you remember those earnings are shrinking, not recovering.
Risk sits in the combination of thin margins and the ethical block that rules the name out regardless of any 14 percent gap to our fair value. Ten analysts call it a hold with an 11 dollar median target. Analysis, not advice.
| Forward P/E | 8.3xvery cheap relative to earnings |
| EPS, trailing | -1.34 |
| EPS, forward | 1.50 |
| Revenue growth | -27.1%revenue is shrinking |
| Profit margin | -28.5%currently unprofitable |
| Return on equity | -6.6%not currently earning a positive return on equity |
| FCF yield | 9.19% |
| Dividend yield | 2,080.00% |
| Debt to equity | 1.23a meaningful debt load worth watching |
| Current ratio | 2.14comfortably covers its short-term bills |
| Beta | 0.91steadier than the market |
| Short interest, float | 0.04% |
| 52-week range | 9.72 - 18.21 |
| Market cap | $3.4B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFSK trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $10.76 | +2.2% | · | $1,022 | +2.2% |
| 2 months | $10.13 | +8.5% | · | $1,085 | +8.5% |
| 3 months | $9.76 | +12.6% | $0.48 | $1,176 | +17.6% |
| 6 months | $14.68 | -25.1% | $0.48 | $782 | -21.8% |
| 1 year | $18.15 | -39.4% | $2.58 | $748 | -25.2% |
| 2 years | $15.18 | -27.6% | $5.38 | $1,079 | +7.9% |
| 3 years | $12.55 | -12.4% | $8.38 | $1,544 | +54.4% |
| 5 years | $11.26 | -2.3% | $13.06 | $2,137 | +113.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FSK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.